Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Garret Roepel is active.

Publication


Featured researches published by Michael Garret Roepel.


Bioorganic & Medicinal Chemistry Letters | 2008

Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Zachary Kevin Sweeney; James Patrick Dunn; Yu Li; Gabrielle Heilek; Pete Dunten; Todd R. Elworthy; Xiaochun Han; Seth F. Harris; Donald Roy Hirschfeld; J. Heather Hogg; Walter Huber; Ann C. Kaiser; Denis John Kertesz; Woongki Kim; Taraneh Mirzadegan; Michael Garret Roepel; Y. David Saito; Tania Silva; Steven Swallow; Jahari Laurant Tracy; Armando G. Villaseñor; Harit Vora; Amy S. Zhou; Klaus Klumpp

A series of benzyl pyridazinones were evaluated as HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs). Several members of this series showed good activity against the wild-type virus and NNRTI-resistant viruses. The binding of inhibitor 5a to HIV-RT was analyzed by surface plasmon resonance spectroscopy. Pharmacokinetic studies of 5a in rat and dog demonstrated that this compound has good oral bioavailability in animal species. The crystal structure of a complex between HIV-RT and inhibitor 4c is also described.


Tetrahedron Letters | 2002

A one-pot radical addition/fragmentation route to ketones and esters

Michael Garret Roepel

Abstract A simple one-pot procedure has been developed that combines carboncarbon bond formation via a radical addition to either substituted enol ethers or ketene acetals, with a subsequent fragmentation reaction to yield ketones and esters. The ‘masked’ methyl carbonyl radical acceptors discovered in this work are either commercially available or easily prepared in one to two steps.


Archive | 2002

2-pyrrolidone derivatives as prostanoid agonists

Todd R. Elworthy; Michael Garret Roepel; David Bernard Smith


Archive | 2002

Prostaglandin analogues_as ep4 receptor agonists

Todd R. Elworthy; Taraneh Mirzadegan; Michael Garret Roepel; David Bernard Smith; Keith Adrian Murray Walker


Bioorganic & Medicinal Chemistry Letters | 2004

Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.

Todd R. Elworthy; Denis John Kertesz; Woongki Kim; Michael Garret Roepel; Lina Quattrocchio-Setti; David Bernard Smith; Jahari Laurant Tracy; Audrey Chow; Fujun Li; Emma R. Brill; Leang K. Lach; Daren McGee; Diana S. Yang; San-San Chiou


Archive | 2002

8-Aza-11-deoxy prostaglandin analogues

Todd R. Elworthy; T. Mirzadegan; Michael Garret Roepel; David Bernard Smith; Keith Adrian Murray Walker


Archive | 2001

2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists

Denis John Kertesz; Michael Garret Roepel


Archive | 2008

2 pyrrolidone derivative as prostanoid agonist

Todd R. Elworthy; Michael Garret Roepel; David Bernard Smith; リチャード エルワーシー,トッド; バーナード スミス,デイビッド; ガレット ローペル,マイケル


Archive | 2002

PROSTAGLANDINANALOGA ALS EP4-REZEPTORAGONISTEN

Todd R. Elworthy; Taraneh Mirzadegan; Michael Garret Roepel; David Bernard Smith; Keith Adrian Murray Walker


Archive | 2002

Prostaglandin analogues as ep4 receptor agonists

Todd R. Elworthy; Taraneh Mirzadegan; Michael Garret Roepel; David Bernard Smith; Keith Adrian Murray Walker

Collaboration


Dive into the Michael Garret Roepel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge